Free Trial

Voyager Therapeutics (VYGR) Insider Trading & Ownership

Voyager Therapeutics logo
$5.75 +0.06 (+1.05%)
(As of 12/20/2024 05:17 PM ET)

Voyager Therapeutics (NASDAQ:VYGR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.53%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$62,186.51
Get VYGR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Voyager Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VYGR Insider Buying and Selling by Quarter

Voyager Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/2/2024Sandell Jacquelyn FaheyInsiderSell5,999$5.82$34,914.18  
1/17/2024Robin SwartzCOOSell2,543$7.15$18,182.45  
1/17/2024Todd Alfred CarterInsiderSell1,266$7.18$9,089.88  
(Data available from 1/1/2013 forward)

VYGR Insider Trading Activity - Frequently Asked Questions

The list of insiders at Voyager Therapeutics includes Alfred Sandrock, Ecor1 Capital, Llc, Glenn Pierce, Julie Burek, Neurocrine Biosciences Inc, Peter P Pfreundschuh, Robert W Hesslein, Robin Swartz, Rock Ventures Iii L.P. Third, Sandell Jacquelyn Fahey, and Todd Alfred Carter. Learn more on insiders at VYGR.

4.53% of Voyager Therapeutics stock is owned by insiders. Learn more on VYGR's insider holdings.

The following insider purchased VYGR shares in the last 24 months: Neurocrine Biosciences Inc ($39,032,821.44).

Insiders have purchased a total of 4,395,588 VYGR shares in the last 24 months for a total of $39,032,821.44 bought.

The following insiders have sold VYGR shares in the last 24 months: Alfred Sandrock ($58,231.71), Ecor1 Capital, Llc ($4,432,520.00), Peter P Pfreundschuh ($94,833.33), Robert W Hesslein ($102,333.61), Robin Swartz ($56,395.46), Rock Ventures Iii L.P. Third ($4,201,493.44), Sandell Jacquelyn Fahey ($34,914.18), and Todd Alfred Carter ($193,692.75).

Insiders have sold a total of 1,093,964 Voyager Therapeutics shares in the last 24 months for a total of $9,174,414.48 sold.

Voyager Therapeutics Key Executives

  • Dr. Alfred W. Sandrock Jr. (Age 66)
    M.D., Ph.D., President, CEO & Director
    Compensation: $1.01M
  • Ms. Robin Swartz (Age 53)
    COO, Principal Financial & Accounting Officer and Acting Chief Business Officer
    Compensation: $661.98k
  • Ms. Jacquelyn Fahey Sandell Esq. (Age 53)
    J.D., Chief Legal Officer
    Compensation: $538.16k
  • Dr. Krystof Bankiewicz M.D.
    Ph.D., Founder
  • Dr. Guangping Gao Ph.D.
    Founder & Member of Scientific Advisory Board
  • Dr. Mark A. Kay M.D. (Age 65)
    Ph.D., Founder
  • Dr. Phillip D. Zamore Ph.D.
    Founder & Member of Scientific Advisory Board
  • Mr. Todd Carter Ph.D. (Age 54)
    Chief Scientific Officer
  • Ms. Michelle Quinn Smith
    Chief Human Resources Officer
  • Dr. Maria Lopez-Bresnahan M.B.A.
    M.D., Senior Vice President of Translational Medicine & Clinical Development


This page (NASDAQ:VYGR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners